Rise of Drug-Resistant Typhoid in Bangladesh
Ceftriaxone-resistant Salmonella Typhi strains are spreading in Bangladesh, raising urgent health concerns.
Yogesh Hooda, Arif Mohammad Tanmoy, Sudipta Deb Nath, Anannya Barman Jui, Al Amin, Hafizur Rahman, Neoyman Nasir Shorkar, Naito Kanon, Md Asadur Rahman, Denise O Garrett, Mohammad Shahidul Islam, ASM Nawshad Uddin Ahmed, Samir K Saha, Senjuti Saha
― 5 min read
Table of Contents
Salmonella Typhi is a type of bacteria that causes a serious illness called Typhoid Fever. It is a big deal in many parts of the world, especially in South Asia. In fact, around 70% of all typhoid cases happen there. Typhoid fever can make you feel really sick, and it can spread from person to person. You can catch it by drinking or eating things that have been contaminated with the bacteria.
Drug-resistant Strains
The Rise ofRecently, some strains of Salmonella Typhi have become resistant to common antibiotics. This is a big worry because it makes treating typhoid fever much harder. Two main antibiotics, Ceftriaxone and azithromycin, are becoming less effective against these resistant strains. In 2016, Pakistan saw an outbreak of a strain called extensively drug-resistant (XDR) Salmonella Typhi. This means that it was resistant to many of the usual treatments. Cases of this resistance have also popped up in Bangladesh, India, and the UK. With doctors often using ceftriaxone as a first choice for treatment in South Asia, there is a pressing need for health officials to be on alert.
The Situation in Bangladesh
In Bangladesh, Salmonella Typhi is the leading cause of bloodstream infections in children over two months old. However, most previous studies focused primarily on the capital city, Dhaka. To get a better picture of the situation, a new network of clinics was set up across the country starting in January 2023. By March 2024, 20 clinics in 11 districts were involved in monitoring typhoid fever cases.
The Outbreak of Ceftriaxone-Resistant Strains
The first ceftriaxone-resistant Salmonella Typhi strain was detected in April 2024 at a clinic in Narayanganj, which is close to Dhaka. Over the months that followed, more cases turned up, leading to a total of 47 cases by September 2024. Most of these cases were from Narayanganj, but a few popped up in other areas, including Dhaka and Barisal. This indicates that the resistant strains are spreading, and the rate at which they are appearing is climbing – going from zero in March to over 5% of all cases by September 2024.
What Happened to the Patients?
From the cases seen, the patients mostly showed signs of fever. Many also complained of headaches, stomach pain, and cough. Most of the patients were treated as outpatients, while a smaller number needed to go to the hospital. Many were initially prescribed antibiotics that turned out to be ineffective. Luckily, all patients made a full recovery.
Learning More About Resistance
To get to the bottom of why these strains are resistant to ceftriaxone, scientists analyzed 17 of the bacteria samples. They figured out that a specific gene, called blaCTX-M-15, was responsible for this resistance. This gene was identical to what was found in similar strains from Pakistan. The bacteria also contained a special piece of DNA known as a plasmid, which helps with the spread of resistance.
The Bigger Picture
The type of Salmonella Typhi that's causing this issue is not commonly seen in Bangladesh. In fact, it represents only a tiny fraction of the bacteria samples collected in the country over the years. However, it is more often found in neighboring countries like India and Nepal. This indicates that there may be a connection or a pathway for these strains to travel across borders.
What Can Be Done?
This situation highlights the importance of keeping a close eye on antibiotic use and disease detection. If health authorities don’t act quickly, the spread of these drug-resistant strains could become a major problem. Patients with the resistant strain are still sensitive to other antibiotics like chloramphenicol and cotrimoxazole, which could be used in treatment. This is like finding out your old, trusty bicycle still works when your fancy car won’t start!
Preparing for the Future
With the quick emergence of resistance, healthcare systems need to prepare for the possibility that other antibiotics, like azithromycin, may eventually become ineffective too. Public education on responsible antibiotic usage is crucial. It's like reminding your friend that just because they can eat a whole pizza doesn't mean they should!
The Role of Vaccination
Alongside careful antibiotic use, getting vaccinated is another vital weapon against typhoid fever. The typhoid conjugate vaccine (TCV) could help to prevent the spread of these bacteria, especially in vulnerable communities. By ensuring more people are vaccinated, we can keep the resistant strains at bay.
Conclusion
In summary, the rise of ceftriaxone-resistant Salmonella Typhi in Bangladesh is an urgent public health issue that calls for immediate action. The unique lineage of this strain, along with its resistance to many antibiotics, poses a significant threat. It is crucial for health officials to ramp up surveillance and Vaccinations. Everyone, including those in charge of global health, needs to be on their toes, ready to tackle this challenge. With ongoing research and proactive measures, we can hope to manage and control this growing concern effectively. So, let’s stay safe, stay smart, and keep those bacteria at bay!
Original Source
Title: Investigation of an ongoing outbreak of ceftriaxone-resistant Salmonella enterica serovar Typhi in Bangladesh
Abstract: We report an outbreak of ceftriaxone-resistant Salmonella Typhi in Bangladesh, with 47 cases identified from April-September 2024. Isolates belong to genotype 4.3.1.2 and harbor the blaCTX- M-15 gene on the pCROB1 plasmid. This unique genotype-plasmid lineage represents a recent introduction, necessitating enhanced surveillance, antimicrobial stewardship, and consideration of vaccination strategies.
Authors: Yogesh Hooda, Arif Mohammad Tanmoy, Sudipta Deb Nath, Anannya Barman Jui, Al Amin, Hafizur Rahman, Neoyman Nasir Shorkar, Naito Kanon, Md Asadur Rahman, Denise O Garrett, Mohammad Shahidul Islam, ASM Nawshad Uddin Ahmed, Samir K Saha, Senjuti Saha
Last Update: 2024-12-26 00:00:00
Language: English
Source URL: https://www.medrxiv.org/content/10.1101/2024.12.24.24319600
Source PDF: https://www.medrxiv.org/content/10.1101/2024.12.24.24319600.full.pdf
Licence: https://creativecommons.org/licenses/by-nc/4.0/
Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.
Thank you to medrxiv for use of its open access interoperability.